01 1Cambrex Charles City, Inc.
01 1CLN-081
01 1U.S.A
NDC Package Code : 59116-7160
Start Marketing Date : 2023-05-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
24
PharmaCompass offers a list of CLN-081 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CLN-081 manufacturer or CLN-081 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CLN-081 manufacturer or CLN-081 supplier.
PharmaCompass also assists you with knowing the CLN-081 API Price utilized in the formulation of products. CLN-081 API Price is not always fixed or binding as the CLN-081 Price is obtained through a variety of data sources. The CLN-081 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zipalertinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zipalertinib, including repackagers and relabelers. The FDA regulates Zipalertinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zipalertinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zipalertinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zipalertinib supplier is an individual or a company that provides Zipalertinib active pharmaceutical ingredient (API) or Zipalertinib finished formulations upon request. The Zipalertinib suppliers may include Zipalertinib API manufacturers, exporters, distributors and traders.
click here to find a list of Zipalertinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zipalertinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zipalertinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zipalertinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zipalertinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zipalertinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zipalertinib suppliers with NDC on PharmaCompass.
We have 1 companies offering Zipalertinib
Get in contact with the supplier of your choice:
